1. Loss of GdpP Function in Staphylococcus aureus Leads to β-Lactam Tolerance and Enhanced Evolution of β-Lactam Resistance
- Author
-
Poon, Raymond, Basuino, Li, Satishkumar, Nidhi, Chatterjee, Aditi, Mukkayyan, Nagaraja, Buggeln, Emma, Huang, Liusheng, Nair, Vinod, Argudín, Maria A, Datta, Sandip K, Chambers, Henry F, and Chatterjee, Som S
- Subjects
Vaccine Related ,Antimicrobial Resistance ,Biotechnology ,Biodefense ,Infectious Diseases ,Prevention ,Emerging Infectious Diseases ,Development of treatments and therapeutic interventions ,5.1 Pharmaceuticals ,Infection ,Anti-Bacterial Agents ,Bacterial Proteins ,Drug Tolerance ,Methicillin-Resistant Staphylococcus aureus ,Microbial Sensitivity Tests ,Staphylococcus aureus ,beta-Lactam Resistance ,beta-Lactams ,GdpP ,beta-lactams ,cyclic-di-AMP ,tolerance ,Microbiology ,Medical Microbiology ,Pharmacology and Pharmaceutical Sciences - Abstract
Infections caused by Staphylococcus aureus are a leading cause of mortality. Treating infections caused by S. aureus is difficult due to resistance against most traditional antibiotics, including β-lactams. We previously reported the presence of mutations in gdpP among S. aureus strains that were obtained by serial passaging in β-lactam drugs. Similar mutations have recently been reported in natural S. aureus isolates that are either nonsusceptible or resistant to β-lactam antibiotics. gdpP codes for a phosphodiesterase that cleaves cyclic-di-AMP (CDA), a newly discovered second messenger. In this study, we sought to identify the role of gdpP in β-lactam resistance in S. aureus. Our results showed that gdpP-associated mutations caused loss of phosphodiesterase function, leading to increased CDA accumulation in the bacterial cytosol. Deletion of gdpP led to an enhanced ability of the bacteria to withstand a β-lactam challenge (2 to 3 log increase in bacterial CFU) by promoting tolerance without enhancing MICs of β-lactam antibiotics. Our results demonstrated that increased drug tolerance due to loss of GdpP function can provide a selective advantage in acquisition of high-level β-lactam resistance. Loss of GdpP function thus increases tolerance to β-lactams that can lead to its therapy failure and can permit β-lactam resistance to occur more readily.
- Published
- 2022